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Summary
Objectives: The purpose of this study is to amplify the knowledge base of the epidemiology,
symptoms, and signs of extrapulmonary tuberculosis (EPTB) in Afghanistan.
Methods: This is a retrospective review of EPTB diagnosed at CURE International Hospital and
CURE Family Health Center (FHC) in Kabul, Afghanistan during a recent 20-month period.
Results: One hundred eighteen cases were identified from patients presenting to the hospital and
FHC. This group represents the spectrum of EPTB seen at a single referral center in Kabul. The ratio
of females to males was 2.03:1. Lymph node tuberculosis comprised the greatest number of EPTB
cases (37.3%, n = 44). The central nervous system was the next most frequent site of EPTB
involvement (20.3%, n = 24), followed in descending order by skeletal, pleural, abdominal,
cutaneous, genitourinary, pericardial, miliary, and breast tuberculosis.
Conclusions: The 2:1 ratio of female to male EPTB cases coincides with the unusual epidemiologic
pattern seen in smear-positive pulmonary TB in Afghanistan. As the first epidemiological report of
EPTB fromAfghanistan, this study illustrates the varied presentations of EPTB that should be known
by healthcare workers throughout the country.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
More than two decades of conflict, from the Soviet invasion in
1979 to the fall of the Taliban in 2001, devastated the health
infrastructure of Afghanistan. In 2002 the Afghan Ministry of
Public Health (MOPH) began to build a new health system* Corresponding author. Tel.: +93 795 043 096.
E-mail addresses: jtp27@georgetown.edu,
johnticeparks@gmail.com (J. Parks).
1201-9712/$36.00 # 2009 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2009.03.023using an innovative structure in which the government and
international donors jointly contracted non-governmental
organizations (NGOs) to provide a basic package of health
services for the nation’s entire population.1 Afghanistan’s
Basic Package of Health Services (BPHS) was published in
March 2003 with a subsequent revision in 2005.2,3 The MOPH
adopted the balanced scorecard (BSC) as a tool to measure
the performance of the NGOs in their delivery of the BPHS.
Baseline studies were done in 2004. The results of comparison
studies completed in 2005 and 2006 demonstrated substan-
tial improvement in the delivery of health services.4—6Published by Elsevier Ltd. All rights reserved.
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stan reflects the wider process of healthcare reconstruction
in the country. Control of communicable diseases is one of the
seven core elements of the BPHS, and TB is one of three
communicable diseases highlighted.3 The BPHS integrates TB
control throughout all four levels of the health system, from
the village health post to the district hospital. Under the
Taliban, the coverage rate of directly observed therapy
short-course (DOTS) hovered around 12%.7 In 2001, the year
the Taliban regime fell, high morbidity and mortality rates of
TB were documented in the country.8 Since 2002, the DOTS
coverage rate has increased steadily through the implemen-
tation of the BPHS. By 2006, DOTS coverage across the
country had reached 97%. Detection, notification, and treat-
ment success rates showed similar trends.7,9
It was noted after the fall of the Taliban, that commu-
nicable diseases posed a distinct threat to Afghanistan
because risk factors such as overcrowding and internally
displaced persons can be compounded in a post-conflict
setting.10,11 Among communicable diseases worldwide, TB
is the second leading cause of death after HIV/AIDS.12,13 TB
kills nearly 2 million people per year, most of whom live in the
lowest income countries. TB control is critical for the devel-
opment of Afghanistan, which has been designated as one of
twenty-two high burden countries that collectively account
for 80% of TB globally.14,15 The rate of multidrug-resistant TB
was reported at 3.4% in 2006,7 a statistic that makes TB
control all the more urgent.
Extrapulmonary tuberculosis (EPTB) accounts for 13—21%
of TB cases in areas of low HIV prevalence;7,16—19 Kabul
represents an area of low HIV prevalence.20 In Afghanistan
EPTB represents one fifth of all diagnosed cases of TB.7 This
study is a hospital-based retrospective analysis of all EPTB
cases diagnosed at CURE International Hospital Kabul and its
associated Family Health Center (FHC) in Kabul during a
recent 20-month period. The city of Kabul is divided into
18 civil/geographical districts. The hospital and FHC are both
located in the southeast of Kabul in District 6. A 2005 census
reported that District 6 had 211 400 residents, 8.5% of the
city’s total population.21 Women made up 48% of the district
population and each household had approximately 5.8 mem-
bers.21 It is difficult to ascertain the exact origins of the
patients presenting to the hospital and FHC. Approximately
three quarters of all hospital inpatients report that they are
from Kabul, the remainder report that they come from
provinces around Afghanistan. However the population of
Kabul has swollen in recent years. A 1986 Kabul census
reported a population of 152 218 in District 6, 11.7% of the
city’s population at that time.22 Although the majority of our
patients report that they are from Kabul, it is possible that
they are recent immigrants to the city. Within the city limits
families are exposed to indoor cooking/heating fires, home
childbirth is still practiced, and water is not always obtained
from city pumps. Even among Kabul residents, the distinction
between urban and rural lifestyles can be blurred.
CURE International, founded in 1996, is an NGO. It cur-
rently operates hospitals in eleven countries, and health
worker education is among its core values. More information
about CURE can be found on its website.23 The CURE hospital
in Kabul has surgical, medical, pediatric, obstetric, and
neonatal services. X-ray, ultrasonography, electrocardio-
graphy, as well as basic blood and fluid analysis (totallymphocyte count, differential, protein, glucose, Gram
stain) can be performed at the hospital. Microbiology cul-
tures are not available at the facility. Computed tomogra-
phy (CT) or magnetic resonance imaging (MRI) scans are not
available at the CURE hospital, but they can be obtained by
patients in Kabul who can afford the $100 to $200 out-of-
pocket expense. CURE hospital has the only pathology
laboratory available to the civilian population in the coun-
try. This is the first research article to use data from a
civilian pathology laboratory in Afghanistan in 30 years.24
This report adds to the local knowledge base by describing
the epidemiology of EPTB in Afghanistan and thus represents
another step forward in the process of reconstructing a
healthcare system in a post-conflict country.
Methods
We conducted a retrospective review of EPTB diagnosed at
CURE International Hospital and the CURE FHC in Kabul,
Afghanistan between November 2006 and July 2008. Cases
of EPTB were identified from the electronic tissue pathology
database at CURE International Hospital, from a review of the
CURE Hospital discharge logbooks, and from the Kabul Dis-
trict 6 TB register. In accordance with diagnostic criteria
established by the World Health Organization,25 a case of
EPTB was defined as TB of organs other than the lungs, e.g.,
pleura, pericardium, lymph nodes, abdomen, genitourinary
tract, skin, joints, bones, meninges. Diagnosis of EPTB in
patients presenting to CURE facilities was based on: (1)
typical histological findings consistent with TB in tissue from
an extrapulmonary site, or (2) strong clinical evidence con-
sistent with active EPTB.
Clinical evidence was defined as the patient’s presenting
symptoms and signs as well as radiographic or body fluid
analysis supporting the diagnosis of EPTB. Tuberculous
meningitis (TBM) was diagnosed based on a clinical presenta-
tion consistent with TBM and a cerebrospinal fluid (CSF)
analysis. CSF with a moderately elevated protein, low glu-
cose, and elevated white blood cell count with a lymphocyte
predominance was considered consistent with TBM.26,27 Clin-
ical evidence for pleural and abdominal TB was defined as
body fluid analysis showing elevated protein, low glucose,
and elevated white blood cells with lymphocyte predomi-
nance with a supporting clinical history. Spinal TB (Pott’s
disease) was diagnosed based on clinical and radiographic
evidence typical for spinal TB. Miliary TB was diagnosed
based on clinical presentation consistent with miliary TB
and a chest X-ray typical for miliary TB.
All cases were exclusively EPTB. If at the time of pre-
sentation a patient was symptomatic for pulmonary TB
(cough, hemoptysis, or constitutional symptoms),28 a chest
radiograph and sputum samples were obtained. A chest
radiograph was not routinely performed on patients thought
to have EPTB but not expressing pulmonary symptoms, due to
the cost burden that would place on the patient and the fact
that it would not alter the decision to initiate anti-TB ther-
apy. Patients found to have concurrent pulmonary and extra-
pulmonary TB were excluded from our sample.
In all cases a clinicianmade thedecision to treat thepatient
with a full course of anti-TB treatment. At the point of
diagnosis the patient was referred back to a government
run TB treatment facility. The closest facility during the time
Figure 1 Cumulative number of males and females diagnosed
with extrapulmonary tuberculosis according to age at diagnosis.
CURE, Kabul, November 2006—July 2008.
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some patients may have chosen to seek treatment at facilities
closer to their homes. Treatment was carried out at those
facilities in accordance with the guidelines of the National
Tuberculosis Control Program (NTP) for Afghanistan.29 Evalu-
ating a patient’s response to anti-TB therapywas not an aim of
this study. Culture confirmation was not used as part of the
diagnostic criteria in this study. To our knowledge, culture
confirmation for TB is not available for the civilian population
inAfghanistan. Acid-fast bacillus (AFB) stainingwas notusedas
a confirmatory test because we lack the reagent. Gram stain-
ing was performed on all body fluid samples. Additional stains
for granulomatous diseases (e.g., fungal, Actinomyces, syphi-
lis) were not performed by the CURE pathology lab due to the
lack of reagents. Purified protein derivative (PPD) skin testing
was not used for diagnostic evaluation in individuals over five
years of age because it is not part of the NTP diagnostic
guidelines.29 PPD was not used in children because we chose
to use the patient’s limited resources on other diagnostic
modalities.
We analyzed cases according to gender, age, site of infec-
tion, presenting complaints, and symptom duration prior to
diagnosis using Microsoft Excel. Due to the limitations of our
record keeping, a complete set of demographic and clinical
data was not available for every patient. Therefore we calcu-
lated averages and ranges using only the demographic and
laboratory data that were available. The sample sizes used to
makecalculations are noted in the results section. A secondary
aim of this study was to determine the relative frequency of
pathologic diagnoses seen in lymph node specimens received
by the pathology laboratory during this time period. The
Afghan Ministry of Public Health Institutional Review Board
has given CURE International Hospital the approval to conduct
this research and disseminate the results.
Results
Between November 2006 and July 2008, 118 cases of EPTB
were diagnosed in patients presenting to CURE International
Hospital and the CURE FHC. Sixty-one percent (n = 72) of the
patients presenting to CURE were diagnosed with the aid of
tissue pathology analysis. The remainder were diagnosed
through clinical symptoms and signs as well as radiographic
or body fluid analysis. Fifty-nine (50%) of the 118 patients
diagnosed at the CURE facilities were also listed in the TB
register, having reported for treatment at the District 6
facility.
Females were more likely to be diagnosed with EPTB than
males by a ratio of 2.03:1 (Figure 1). The average age of all
patients with EPTB at the time of diagnosis was 31.5  17.77
years (n = 116). The average age of males at the time of
diagnosis was 32.2  21.80 years (n = 39). Females had an
average age of 31.1  15.59 years at diagnosis (n = 77). There
were seventeen (14.4%) patients at the time of diagnosis
aged 15 years and younger. Nine of these children were
female.
Among the 118 cases who presented to CURE Hospital, we
have records for the duration of symptoms prior to diagnosis
for 90 (76.3%) patients. The average duration of symptoms
before presentation was 14.8 months for men (n = 31) and
18.0 months for women (n = 59). Twenty-four women
reported symptoms lasting one year or longer compared to10 men. When we removed 22 cases of TBM from the analysis,
the average duration of symptoms before presentation was
23.0 months for men (n = 19) and 18.9 months for women
(n = 49).
Lymph node TB (LNTB) comprised the greatest number of
EPTB cases (37.3%, n = 44) (Figure 2, Table 1). The average
age at the time of diagnosis was 25.1  11.84 years (n = 42).
Among children aged 15 years and younger, nine (52.9%) were
diagnosed with LNTB. Cervical lymph nodes were the most
common site of infection (81.8%, n = 36), followed by axillary
lymph nodes (13.6%, n = 6). Symptoms were present for an
average of 1.76 years prior to presentation (n = 30). The most
common symptoms of lymph node TB were swelling of the
affected area (90.9%, n = 40), fever (52.3%, n = 23), and
weight loss (36.4%, n = 16). Five patients (11.4%) reported
painful lymph nodes at the time of presentation.
During the 20-month period of this study the CURE pathol-
ogy department examined 257 lymph node specimens.
Twenty-five percent of lymph nodes examined by the pathol-
ogy department at CURE were histologically compatible with
TB. Other lymph node diagnoses included lymphoma (29.6%),
carcinoma (8.9%), reactive hyperplasia (8.6%), and histiocy-
tosis (5.1%).
The central nervous system was the next most frequent
site of EPTB involvement (20.3%, n = 24). Twenty-three cases
were diagnosed as TBM. One patient was found to have an
intracranial tuberculoma by CT scan. The most common
symptoms for TBM at presentation were headache (69.6%,
n = 16), fever (60.9%, n = 14), and vomiting (60.9%, n = 14).
Five patients (21.7%) were unconscious at the time of pre-
sentation to the hospital or health center. The average
duration of symptoms was 2.7  3.27 months (n = 22) prior
to presentation. Six patients (26.1%) had neck stiffness at the
time of physical examination. Data concerning permanent
neurologic sequelae from TBMwere not recorded. A summary
of CSF findings can be found in Table 2.
Skeletal TB (n = 14) was found in the spine, elbow, knee,
and forearm. Fifty percent (n = 7) of cases were spinal TB. Six
spinal TB cases had radiographic evidence (X-ray, CT, or MRI)
for TB. One case of spinal TB was confirmed through
Figure 2 Percentage of cases of extrapulmonary tuberculosis diagnosed from patients presenting to CURE International Hospital and
the CURE FHC in Kabul. Cases are grouped according to site of diagnosis.
Extrapulmonary tuberculosis in Kabul, Afghanistan e105histologic examination. Common symptoms of spinal TB
included fever (100%, n = 7), progressive lower extremity
weakness or paraplegia (71.4%, n = 5), and back pain
(57.1%, n = 4). The most common complaint in non-spinalTable 1 Cases by site of diagnosis including numbers of females
Type Cases
(n)
Percentage of
total cases
Female
(n)
Female age
<30 years
Lymphangitic 44 37.3% 31 31
CNS 24 20.3% 12 7
Skeletal 14 11.9% 8 1
Pleural 10 8.5% 6 1
Abdominal 8 6.8% 8 4
Cutaneous 6 5.1% 3 2
Genitourinary 6 5.1% 5 3
Pericardial 3 2.5% 3 1
Miliary 2 1.7% 2 0
Breast 1 0.8% 1 1
Total 118 100% 79
N/A, not applicable; CNS, central nervous system.
a n = 30.
b n = 12.
Table 2 Analysis of fluid samples from selected body sites
Cerebrospinal fluid Pleura
Range of total
WBC count
10—600  106 cells/l (n = 23) 63—18
Lymphocytosis 20 of 21 CSF samples
demonstrated lymphocytosis
4 of 6
demon
Protein (range) 3—2000 mg% Average
= 95.8 mg% (n = 14)
2800—
= 11 3
Glucose (range) 8—113 mg% Average
= 37.6 mg% (n = 20)
26—19
= 116.
WBC, white blood cell; CSF, cerebrospinal fluid.skeletal TB was swelling of the affected joint (n = 4); in three
of the four cases this was painful swelling.
Pleural TB accounted for 8.5% of cases (n = 10). In four
cases the diagnosis relied on pleural biopsy samples, theand males and average ages at time of diagnosis
d
(n)
Average age
female, years
Male
(n)
Male aged
<30 years (n)
Average age
male, years
25.69a 13 8 23.58b
28.0 12 9 24.4
46.0 6 2 54.2
41.0 4 0 49.8
29.3 0 N/A N/A
34.0 3 0 37.3
27.6 1 1 12.0
45.0 0 N/A N/A
42.5 0 N/A N/A
15.0 0 N/A N/A
39
l fluid Ascitic fluid
00  106 cells/l (n = 6) 55—1600  106 cells/l (n = 4)
pleural fluid aspirates
strated lymphocytosis
3 of 4 peritoneal fluid aspirates
demonstrated lymphocytosis
26 300 mg% Average
00 mg% (n = 3)
34 000 mg% (n = 1)
6 mg% Average
8 mg% (n = 3)
64—82 mg% Average
= 73.0 mg% (n = 2)
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toms were shortness of breath (50%, n = 5) and cough (50%,
n = 5). A summary of the pleural fluid analysis can be found in
Table 2.
Four of the eight cases of abdominal TB were peritonitis
diagnosed by clinical examination and analysis of ascitic fluid
obtained by paracentesis (see Table 2). The other four cases
of intra-abdominal TB were diagnosed from biopsy specimens
of the small intestine, mesentery, or peritoneum. Reported
symptoms of gastrointestinal TB at presentation included
weight loss (75%, n = 6), fever (50%, n = 4), and abdominal
distention (37.5%, n = 3).
Sites of cutaneous TB included ear, forehead, the gluteal
area, wrist, and flank.
Six patients during this time period were diagnosed with
genitourinary TB (GUTB). Five were women with an average
age of 27.6 years. Three of the five women with GUTB had TB
of the endometrium and two of these presented because of
infertility.
During the 20-month time period, three patients (2.5%)
presented with pericardial TB. All patients were found to
have a pericardial effusion. Two of the patients with peri-
cardial TB presented with shortness of breath.
Two cases of miliary TB and one case of breast TB were
diagnosed. Patients with miliary TB were found to have
constitutional symptoms (fevers, chills, sweats) and a chest
X-ray typical for miliary TB. One case of breast TB was
diagnosed in a 15-year-old female who reported six months
of a gradually increasing painful breast mass.
Discussion
In 2006, 21% of new cases of TB reported in Afghanistan were
extrapulmonary.7 In the 20-month period of our study, the
District 6 TB register (the DOTS register for the area of Kabul
we work in) showed 214 cases of extrapulmonary tubercular
disease out of 390 recorded TB cases. This high percentage of
EPTB (54.9%) is thought to be an over-representation and
therefore not comparable to other reports. The reason for
this is that patients in Kabul will often travel to our hospital
to receive a copy of their pathologic diagnosis regardless of
the origin of the tissue specimen. If diagnosed with EPTB the
patient will then be referred to an NTP treatment facility.
The closest one to the hospital during the time of our study
was the District 6 facility. The fact that only 50% of cases
diagnosed at our facility were found in the District 6 register
raises questions about our TB reporting. It is possible thatTable 3 Signs and symptoms of extrapulmonary tuberculosis in K
Lymph node Indolent usually painless, lymph node swe
Meningeal Prolonged headache, fever and vomiting,
neck. CSF typically shows moderate eleva
elevated protein, and low glucose
Spinal Localized back pain and lower extremity
associated with fever
Pleural Cough, shortness of breath and signs of a
Abdominal Weight loss, fever and abdominal distenti
Endometrial Infertility in a reproductive age female
Pericardial Shortness of breath and signs of pericardipatients were referred to the District 6 TB clinic but chose to
seek care at a clinic closer to their home. Because we are the
only civilian facility providing pathologic diagnosis, it is
conceivable that patients are returning to their home pro-
vinces or one of the other 18 Kabul districts for TB treatment.
It is also possible that the patients, once diagnosed with TB,
are choosing not to seek treatment.
The cause of the long delay in diagnosis of EPTB is probably
multifactorial. The delay could be due to the indolent nature
of EPTB. It could reflect health-seeking behaviors of the
population. It could also represent a failure of health provi-
ders to recognize EPTB. It is important for healthcare pro-
viders in areas of high TB prevalence, such as Afghanistan, to
consider EPTB as a diagnostic possibility in order to make a
prompt diagnosis and to prevent unnecessary invasive pro-
cedures. Common clinical symptoms and signs that should
increase a primary care provider’s suspicion of EPTB in
Afghanistan are listed in Table 3. This country-specific infor-
mation could be distributed throughout the healthcare sys-
tem, from the health post to the district hospital, in order to
increase recognition and thus control of TB.
Health-seeking behavior is likely to affect the time
between symptom onset and diagnosis in Afghanistan. In
2002, women at health centers in Kabul were asked a series
of questions about their healthcare knowledge and beha-
viors. Ninety-three percent reported needing authorization
from their husband or a male relative before seeking profes-
sional health care.30 House staff at our hospital report anec-
dotally that there is a stigma among both male and female
patients associated with the diagnosis of TB. Reports of
stigma related to the diagnosis of TB have been documented
elsewhere in the developing world.31—33 Stigma associated
with the diagnosis may cause a delay in seeking care. A better
understanding of these relationships in Afghanistan could
help inform public health education programs.
The female to male ratio of EPTB cases in this study was
2.03:1. In 2006 the female to male ratio for all cases of newly
diagnosed smear positive (ss + ) pulmonary TB cases in Afgha-
nistan was 2.13:1.7 In a recent study from southeastern Iran,
all forms of newly diagnosed TB had a female to male ratio of
1.46:1.34 Afghanistan and Iran reflect an unusual epidemio-
logic pattern in that the majority of pulmonary TB patients
are women. In other areas of the world, pulmonary TB is
predominantly a disease of males.17,19 In series from South
America, Nepal, and Turkey, males were also more frequently
diagnosed with EPTB.35—38 However, reports from Hong Kong
and Germany have noted a female majority in cases ofabul, Afghanistan
lling, which may be associated with fever or weight loss
often with altered mental status, usually without a stiff
tion of white blood cells with a lymphocyte predominance,
weakness. Vertebral tenderness and deformity, often
pleural effusion by physical examination, X-ray or ultrasound
on
al effusion
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cause behind the higher incidence of TB infection in females
in this region.
Vitamin D is one modifiable risk factor that may play a role
in the high female prevalence of TB in Afghanistan. Low
serum vitamin D levels have been associated with a higher
risk of active TB.39—43 A cellular explanation for the associa-
tion between vitamin D and TB has been proposed.44—46
Important determinants of vitamin D deficiency are skin type,
sex, clothing, nutrition, food fortification, use of supple-
ments, high body mass index, and degree of urbanization.47
Vitamin D deficiency (defined as serum vitamin D<25 nmol/l)
has been demonstrated in both men and women in Jordan,
Lebanon, and Iran, countries which share a number of similar
geographic and cultural characteristics with Afghani-
stan.47,48 In Iran, females between the ages of 20 and 39
years had significantly lower levels of serum vitamin D than
other groups.49 In Jordan and Lebanon it appears that a
higher percentage of women are vitamin D deficient com-
pared to men.47 Unpublished data from our facility revealed
a vitamin D deficiency in pregnant women in Kabul.50 The
causes of these discrepancies between the sexes have not
been fully elucidated. Demonstrating a relationship between
vitamin D deficiency and TB in Afghanistan would have
important public health implications. Vitamin D supplemen-
tation has already been shown to be beneficial in patients
with active TB,51 but has not yet been studied as a low cost
preventive agent. It is possible that the prevalence of active
TB could be reduced by vitamin D fortification of food, or by
providing vitamin D supplementation to targeted populations
at risk for TB.
The lymph nodes were the most common site of EPTB in
our study (37.3%), and LNTB was more frequent among
reproductive age females. The most frequent site of EPTB
in children aged 15 years and under was the lymph nodes,
accounting for the majority (52.9%) of cases in children.
These findings are consistent with previous reports from
the developing world.16 Tuberculous meningitis (20.3%)
was the second most common form of EPTB in our series.
This finding represents an unusual epidemiologic pattern. In
other reports TBM has accounted for approximately 5% of
EPTB cases.16 We do not know the reason for this distribution.
Referral bias may be partly responsible for our larger per-
centage of diagnosed TBM cases. Our facility’s ability to
perform lumbar puncture and analyze CSF enhances our
ability to diagnose the disease. AFB staining would further
increase the diagnostic accuracy. Most patients self-refer in
our environment, and our ability to provide better diagnos-
tics may mean we receive patients who have not responded
to treatment by other providers. There are many possible risk
factors for TB infection in Afghanistan. Any number of these
factors, or an unrecognized risk factor, could also contribute
to the higher percentage of TBM in our series. The rate of
permanent neurologic sequelae from TBM has been reported
at between 4% and 21%.52—55 Due to difficulties with follow-
up we are not able to present data on neurologic sequelae in
our TBM patients. In a high burden area such as Afghanistan,
primary healthcare workers should have a high level of
suspicion for this potentially devastating illness in order to
diagnose and treat it promptly.
Risk factors for TB infection relevant to Afghanistan include
living inahighprevalence region, internally displacedpersons,poverty,56 crowded living conditions,57 undernutrition,58 low
levels of education,59 use of glucocorticoids,60—62 malig-
nancy,63 celiac disease,64 cigarette smoking,65 genetic predis-
position,66 drinking unpasteurized milk,67,68 and vitamin D
deficiency.43 It is not yet clear which of these factors, if
any, had an influence in the high percentage of TBM seen in
our series.
The ingestion of raw milk is one of the known risk factors
for TB infection.68 Many Afghans, particularly in rural areas,
consume unpasteurized milk from goats, cows, or sheep.
These animals are susceptible hosts for Mycobacterium
bovis.69 It is impossible clinically or pathologically to distin-
guish the different species of mycobacteria. It is only possible
with expensive laboratory equipment that is not currently
available in this setting.67 In our series the species of myco-
bacteria causing abdominal infection is unknown and it is
possible that some cases of active disease could have been
caused by species other than Mycobacterium tuberculosis.
Regardless of mycobacterial species the diagnosis of abdom-
inal TB can be difficult. Intra-abdominal TB can mimic con-
ditions such as intra-abdominal malignancy or inflammatory
bowel disease, and thus presents a diagnostic challenge.
Tissue pathology provides a powerful tool to assess for gran-
ulomas and differentiate between other causes of intra-
abdominal disease.
HIV infection is unlikely to be a significant risk factor for
TB in Afghanistan at this time. In a recent series, Todd et al.
found that 0.2% of patients undergoing treatment at a TB
clinic in Kabul were co-infected with HIV.20 The World Health
Organization defines HIV-prevalent settings as an area where
HIV prevalence among TB patients is 5%.70 For this reason,
and because of cost constraints, we did not screen our
patients for HIV disease. As the prevalence of HIV in Afghani-
stan increases, it will be more important to screen TB
patients for HIV. Since HIV is more common in EPTB
patients,27,71 this group should be watched more closely.
Infertility has been reported as the most common com-
plaint of women with TB endometritis.72,73 Women with
infertility should be screened for symptoms of GUTB, espe-
cially abnormal uterine bleeding and lower abdominal pain.
An endometrial biopsy is a simple procedure that can lead to
the diagnosis and treatment of GUTB, and resolution of
infertility.
In our study 6 of 72 diagnoses (8.3%) made in the pathology
laboratory were done with tissue obtained through fine
needle aspiration. Fine needle aspiration cytology (FNAC)
is a safe, cost-effective, and minimally invasive means to
diagnose EPTB.74 It has been shown to be effective in diag-
nosing TB of the lymph node, breast, and testis.75—79 Diag-
nosis by FNAC can avoid an unnecessary mastectomy or
orchiectomy. FNAC is particularly useful to distinguish TB
lymphadenitis from other disease in a TB endemic country
with limited resources. Because this is a cost-effective and
safe technology there may be a role for using FNAC in the
more peripheral parts of the Afghan healthcare system.
There are weaknesses in this study. Many Afghans do not
know their true age. Ages obtained may represent estimates
by patients or physicians. Medical records were at times
incomplete. The lack of AFB stain and the absence of culture
for confirmation are also a weakness. An experienced pathol-
ogist can often diagnose a tissue specimen based on its
morphological characteristics. We are fortunate to have
e108 T. Fader et al.telepathology consultation for difficult cases. However,
because of atypical presentations it is recommended to
define an etiological agent by special stains or cultures.80
While a civilian pathology laboratory adds greatly to the
diagnostic tools available to clinicians in Afghanistan, the
lack of special stains and cultures are among the limitations
of our laboratory capabilities. There are no data on the
relative frequency of granulomatous disease in Afghanistan.
Data from Pakistan and Oman suggest that syphilis is seen
much less frequently than TB, and brucellosis is slightly more
common.81,82 Following the patient’s response to treatment
would have been useful for clinicians given the diagnostic
limitations. However, because the patients are followed at
NTP TB clinics we do not possess the data regarding treat-
ment outcomes. This represents another weakness. These
weaknesses point to challenges in obtaining new knowledge
within a post-conflict health system.
Medical research is a helpful component in rebuilding a
healthcare system in a country devastated by conflict. In fact
‘making evidence-based decisions’ is one of the seven prin-
ciples of the BPHS.3 Policy makers realize the benefit of
population-specific information in order to guide sound policy
decisions. Protocols for disease management are often based
on the results of research done in the developed world. It is
not always possible or advisable to generalize those conclu-
sions to the developing world.83 Building local research
capacity is needed to inform cost-effective clinical deci-
sion-making in settings with limited resources. The informa-
tion presented within this paper is intended to amplify the
clinician’s knowledge base at all levels of the health system
about EPTB in the Afghan population.
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